Previous 10 | Next 10 |
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, wi...
Twist Bioscience (NASDAQ: TWST ) announces encouraging in vitro study data on immunoglobulin (IgG) and smaller single domain VHH "nanobodies" (antigen-binding fragments of heavy chain-only antibodies) against SARS-CoV-2. The observed neutralizing effects were comparable to or better th...
-- Data compiled in collaboration with Saint Louis University and independently verified by Colorado State University -- Twist Bioscience Corporation (Nasdaq: TWST) today announced data demonstrating the potent neutralizing effects of multiple potential therapeutic antibodies, both Imm...
Twist Bioscience (NASDAQ: TWST ) announces that an episode of Neflix's "Biohackers" has been stored in its synthetic DNA. More news on: Twist Bioscience Corporation, Healthcare stocks news, Tech stocks news, Read more ...
-- World’s First Series Stored in DNA -- Twist Bioscience Corporation (Nasdaq: TWST) today announced that for the first time, an episode of a Netflix Original Series has been stored in Twist’s synthetic DNA. This press release features multimedia. View the full release ...
Not that long ago, I wrote an article asking how long investors would tolerate the growth-at-all-costs business model of Twist Bioscience (NASDAQ: TWST) . Shares have responded by soaring over 200% in 2020. I nailed it. The DNA synthesis company has poured money into a rapid business e...
Twist Bioscience Corporation (TWST) Q3 2020 Earnings Conference Call August 6, 2020 16:30 ET Company Participants Jim Thorburn - Chief Financial Officer Emily Leproust - Chief Executive Officer & Co-Founder Conference Call Participants Subbu Nambi - Cowen Luke Sergott -...
Image source: The Motley Fool. Twist Bioscience Corp (NASDAQ: TWST) Q3 2020 Earnings Call Aug 7, 2020 , 10:30 p.m. ET Operator Continue reading
The following slide deck was published by Twist Bioscience Corporation in conjunction with their 2020 Q3 earnings Read more ...
Twist Bioscience (NASDAQ: TWST ) : Q3 GAAP EPS of -$0.67 beats by $0.15 . More news on: Twist Bioscience Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...